PLRX Q1 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-92.5% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$23M-1054.2% margin

Net Income

-$23M-1051.3% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

-51.3%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$275M

Total Liabilities

$11M

Stockholders' Equity

$264M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$29M	-92.5%
Gross Profit	$2M	$29M	-92.5%
Operating Income	-$23M	$11M	-308.2%
Net Income	-$23M	$11M	-307.2%